The Nanopore Sensors segmentation by application delineates four primary domains that collectively drive market revenue. DNA sequencing remains the dominant segment, accounting for roughly 45% of total sales, as its high-throughput capability and decreasing per‑base cost attract genomics research, clinical diagnostics, and personalized medicine. Protein analysis follows with an estimated 30% share, leveraging nanopore‑based proteomics to enable real‑time peptide identification, folding studies, and biomarker discovery, thereby expanding the sensor base beyond nucleic acids. Environmental monitoring contributes about 15% of the market, where portable nanopore devices detect pathogens, toxins, and microbial contamination in water, air, and soil, meeting regulatory and public‑health demands. The residual 10% is classified as other applications, encompassing food safety testing, forensic analysis, and synthetic biology platforms. Each application segment not only reflects distinct end‑user requirements but also influences the allocation of R&D resources, pricing strategies, and geographic adoption patterns within the overall Nanopore Sensors market.